Immunomedics

YTD

ALL

Why Robinhood?

You can watch Immunomedics and buy or sell other stocks, ETFs, and their options commission-free!

About IMMU

Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer.

CEO

Harout Semerjian, MBA

CEOHarout Semerjian, MBA

Employees

—

Employees—

Headquarters

Morris Plains, New Jersey

HeadquartersMorris Plains, New Jersey

Founded

1982

Founded1982

Employees

—

Employees—

IMMU Key Statistics

Market cap

20.31B

Market cap20.31B

Price-Earnings ratio

-51.04

Price-Earnings ratio-51.04

Dividend yield

—

Dividend yield—

Average volume

5.59M

Average volume5.59M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$87.93

52 Week high$87.93

52 Week low

$8.80

52 Week low$8.80

People also own

Based on the portfolios of people who own IMMU. This list is generated using Robinhood data, and it’s not a recommendation.